Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.J.J. Body, R.D. Rubens, H. Fleisch et al.|Journal of Clinical Oncology|1998Cited by 366
2LBA Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 studyAlison Stopeck, J.J. Body, Yasuyuki Fujiwara et al.|European Journal of Cancer Supplements|2009Cited by 84
Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cellsFabrice Journé, J.J. Body|British Journal of Cancer|2004Cited by 22
P3-16-07: Denosumab in Patients with Breast Cancer and Bone Metastases Previously Treated with Zoledronic Acid or Denosumab: Results from the 2-Year Open-Label Extension Treatment Phase of a Pivotal Phase 3 Study.A. Stopeck, Ada Braun, Allan Lipton et al.|Cancer Research|2011Cited by 15